Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
about
Lipoprotein-associated oxidative stress: a new twist to the postprandial hypothesisCelastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stressIsorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 inductionSimvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering EffectTrapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation.Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins.The Dynamics of Oxidized LDL during Atherogenesis.Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.LDL biochemical modifications: a link between atherosclerosis and aging.Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice.Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosisAntigen-induced immunomodulation in the pathogenesis of atherosclerosis.Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases.Loss of Caspase-Activated DNase Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice.The Application of a Modified d-ROMs Test for Measurement of Oxidative Stress and Oxidized High-Density Lipoprotein.Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitisThe recognition of biomaterials: pattern recognition of medical polymers and their adsorbed biomolecules.Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.Macropinocytosis contributes to the macrophage foam cell formation in RAW264.7 cells.Hyperlipidemia induces endothelial-derived foam cells in culture.PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1Effect of leptin and insulin resistance on properties of human monocytes in lean and obese healthy participants.Liraglutide reduces oxidized LDL-induced oxidative stress and fatty degeneration in Raw 264.7 cells involving the AMPK/SREBP1 pathway.LDL attenuates VEGF-induced angiogenesis via mechanisms involving VEGFR2 internalization and degradation following endosome-trans-Golgi network trafficking.Identification, expression and function of apolipoprotein E in annual fish Nothobranchius guentheri: implication for an aging marker.Downstream effects on human low density lipoprotein of homocysteine exported from endothelial cells in an in vitro system.Oxidized-low density lipoprotein in gingival crevicular fluid of patients with chronic periodontitis: a possible link to atherogenesis.Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.Lipids on the Second Day in Ischemic and Normoxemic Term Neonates.
P2860
Q26828643-B9B6DA93-8FF1-40B2-A1FD-D350A68A2F73Q28533974-53685DD1-E2A1-4232-A8F4-3D5D014AE9F6Q28544863-11BFCBD5-8E94-4727-8356-9739E897F1B8Q28553042-D4EB098D-1051-4A66-83D7-B54F3E9CBDBDQ33694286-8101BA09-BA54-4436-A657-26897FBD2DA7Q34513543-C73C0C35-B284-4247-989A-DBF3B1FD466FQ35024665-26D651A3-3FD6-41CC-9550-FC2F357491F7Q35871129-37CCD33F-2D07-431F-860A-315B700FD45EQ36348442-9EEBD1AC-2160-4B50-A507-A4C996EF3863Q36872076-EA7D36D1-274E-4AEB-8A1C-816314D71433Q37032384-A1BDE7E8-0C63-4627-8365-8607D2EF9D2EQ37080012-F764E445-D143-45AD-B4C1-1A27CDE0B55EQ37190468-DA3D5BA4-BEC5-4ADF-B50E-E2496ABC3D17Q37275036-33D48CBE-4A5D-4AC5-B428-64FB2785C5B0Q37556276-D4632A78-D9C8-44BD-AD12-CBBB1E5F2902Q37691069-23AFCBF7-6E6A-4EE3-A86A-318D6AADFFD7Q38026551-A135A6E8-4D44-499D-8F31-06A915BFFB3CQ38101310-0623B123-80DB-4694-BEB8-922408F0D263Q39153624-F7DF4C63-699F-45CE-BB0A-94BFACE854C7Q39804195-14CF0F2B-B7EC-4609-9645-421AAAF37229Q39895867-FC77D829-3A54-4BA8-A780-DC80CF0BF000Q42109973-B04A215E-9549-4F8F-B798-200EE88001E0Q42169805-90671533-055F-470D-ABE8-20964B664F43Q42972408-9EA2827E-BB30-47BB-B352-2461A5339CC0Q43740142-C6439520-0A40-4579-AFDE-2B64CCA44511Q44538811-F98496C3-A60C-437A-B043-6455E58FEC00Q45171661-C536CD74-9457-4ECB-95D3-F73A13DCFE49Q46367955-27A0AEC1-9E46-4966-A254-9197A0DD13EFQ46607739-FD03689D-A775-4529-A44A-E5252D6D77DAQ48218402-2BFF415E-E08D-464F-AF24-F5DFF07290F0
P2860
Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
@en
type
label
Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
@en
prefLabel
Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
@en
P356
P1476
Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
@en
P2093
Hiroyuki Itabe
P356
10.1248/BPB.26.1
P577
2003-01-01T00:00:00Z